MedTrace Logo

Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery

NCT03071913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-09-27

No results posted yet for this study

Summary

This pilot research trial studies blood brain barrier differences in patients with brain tumors undergoing surgery. Studying samples of tissue and blood from patients with brain tumors in the laboratory may help doctors to understand how well drugs get into different parts of a brain tumor. This may help them to determine which types of drugs may be best for treating brain tumors.

Conditions

  • Central Nervous System Neoplasm
  • Localized Brain Neoplasm
  • Metastatic Malignant Neoplasm in the Brain
  • Recurrent Brain Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of tissue and blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Jann N. Sarkaria, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-20
Primary Completion
2023-01-11
Completion
2023-01-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071913 on ClinicalTrials.gov